查看文章

Thank you very much for inviting us to comment on the “letter to the editor” by Lechien et al. entitled “Dysphonia in COVID-19 Patients: Direct or indirect Symptom?”. Certainly, this indicates your keenness to advance in the field of scientific research. Our comments on the abovementioned manuscript are presented below. The SARS-CoV-2 invade the target cells that contain angiotensinconverting enzyme 2 (ACE2), although this enzyme is distributed mainly in the respiratory and gastrointestinal tracts, it can enter any cell in the body [1][2]. Therefore, there is a diversity and wide range of COVID-19 symptoms. We concentrated in our published article “Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq” in the Materials and Methods section on the most common symptoms and followed them by the abbreviation, etc.. as it appears in the following sentence [presenting symptoms …